Barings’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$267K Sell
1,094
-761
-41% -$177K ﹤0.01% 164
2025
Q4
$384K Sell
1,855
-145
-7% -$28.7K 0.01% 148
2025
Q3
$371K Hold
2,000
0.01% 150
2025
Q2
$306K Buy
2,000
+49
+3% +$7.53K 0.01% 157
2025
Q1
$324K Sell
1,951
-197
-9% -$30.8K 0.01% 151
2024
Q4
$311K Buy
2,148
+781
+57% +$121K 0.01% 151
2024
Q3
$222K Buy
+1,367
New +$218K 0.01% 155
2024
Q2
Sell
-1,370
Closed -$217K 162
2024
Q1
$217K Buy
+1,370
New +$218K 0.01% 151
2023
Q4
Sell
-1,335
Closed -$208K 154
2023
Q3
$208K Sell
1,335
-651
-33% -$107K 0.01% 143
2023
Q2
$329K Buy
1,986
+333
+20% +$53.7K 0.01% 140
2023
Q1
$256K Sell
1,653
-3,978
-71% -$642K 0.01% 147
2022
Q4
$995K Sell
5,631
-658
-10% -$114K 0.04% 121
2022
Q3
$1.03M Sell
6,289
-14,332
-70% -$2.43M 0.04% 118
2022
Q2
$3.66M Buy
20,621
+6,353
+45% +$1.13M 0.13% 94
2022
Q1
$2.53M Sell
14,268
-3,829
-21% -$652K 0.08% 124
2021
Q4
$3.1M Buy
18,097
+620
+4% +$102K 0.08% 127
2021
Q3
$2.82M Buy
17,477
+8,299
+90% +$1.42M 0.06% 130
2021
Q2
$1.51M Sell
9,178
-1,028
-10% -$170K 0.04% 185
2021
Q1
$1.68M Sell
10,206
-3,144
-24% -$509K 0.04% 179
2020
Q4
$2.1M Sell
13,350
-78,689
-85% -$11.6M 0.05% 165
2020
Q3
$13.7M Sell
92,039
-9,339
-9% -$1.38M 0.31% 51
2020
Q2
$13.3M Hold
101,378
0.44% 40
2020
Q1
$13.3M Buy
101,378
+1,457
+1% +$207K 0.44% 40
2019
Q4
$14.6M Sell
99,921
-19,044
-16% -$2.58M 0.39% 43
2019
Q3
$15.4M Sell
118,965
-48
-0% -$6.32K 0.34% 69
2019
Q2
$16.6M Buy
119,013
+31,801
+36% +$4.4M 0.36% 66
2019
Q1
$12.2M Sell
87,212
-4,584
-5% -$614K 0.28% 70
2018
Q4
$11.8M Sell
91,796
-44,512
-33% -$6.21M 0.21% 80
2018
Q3
$18.8M Buy
136,308
+17,106
+14% +$2.27M 0.27% 66
2018
Q2
$14.5M Sell
119,202
-2,639
-2% -$329K 0.21% 81
2018
Q1
$15.6M Sell
121,841
-6,900
-5% -$933K 0.22% 66
2017
Q4
$18M Buy
128,741
+28,030
+28% +$3.9M 0.23% 72
2017
Q3
$13.1M Sell
100,711
-11,640
-10% -$1.54M 0.23% 69
2017
Q2
$14.9M Sell
112,351
-266,655
-70% -$34M 0.43% 50
2017
Q1
$47.2M Buy
379,006
+196,035
+107% +$23.4M 0.53% 23
2016
Q4
$21.1M Sell
182,971
-23,950
-12% -$2.77M 0.53% 12
2016
Q3
$24.4M Sell
206,921
-37,810
-15% -$4.59M 0.63% 11
2016
Q2
$29.7M Sell
244,731
-25,580
-9% -$2.91M 0.77% 6
2016
Q1
$29.2M Buy
270,311
+73,250
+37% +$7.58M 0.78% 9
2015
Q4
$20.2M Buy
197,061
+57,890
+42% +$5.82M 0.51% 17
2015
Q3
$13M Sell
139,171
-78,899
-36% -$7.63M 0.32% 39
2015
Q2
$21.3M Sell
218,070
-82,280
-27% -$8.24M 0.64% 21
2015
Q1
$30.2M Buy
300,350
+32,160
+12% +$3.27M 0.69% 9
2014
Q4
$28M Buy
268,190
+29,410
+12% +$3.1M 0.62% 13
2014
Q3
$25.5M Sell
238,780
-20,860
-8% -$2.16M 0.55% 18
2014
Q2
$27.2M Buy
259,640
+29,740
+13% +$3.01M 0.82% 14
2014
Q1
$22.6M Sell
229,900
-16,200
-7% -$1.5M 0.71% 19
2013
Q4
$22.5M Sell
246,100
-17,700
-7% -$1.63M 0.94% 15
2013
Q3
$22.9M Buy
263,800
+6,300
+2% +$565K 0.98% 12
2013
Q2
$22.1M Buy
+257,500
New +$21.9M 0.99% 13

Other funds holding JNJ

Barings's JNJ Position: Q1 2026 in Review

Barings reduced its Johnson & Johnson (JNJ) stake by 41% in Q1 2026, selling an estimated $177K and leaving 1,094 shares worth $267K. The position accounts for ﹤0.01% of the portfolio, ranked #164.

Barings first reported a position in JNJ in Q2 2013 and has held it in 50 quarters since. The position peaked at $47.2M in Q1 2017. 4,617 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Barings held 1,094 shares of Johnson & Johnson worth $267K as of Q1 2026.
  • Barings sold 761 Johnson & Johnson shares in Q1 2026, an estimated $177K.
  • Johnson & Johnson made up ﹤0.01% of Barings's portfolio in Q1 2026, its #164 holding.
  • Barings first reported a position in Johnson & Johnson in Q2 2013 and has held it in 50 quarters since.
  • Barings's Johnson & Johnson position peaked at $47.2M in Q1 2017.
  • 4,617 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Barings's 13F filing for Q1 2026, filed 6 May 2026.